Why the study?
To compare the impact of a care bundle with pharmacist discharge medication reconciliation versus standard of care on continuity of therapeutic changes and patient outcomes.
Does a discharge care bundle including medication reconciliation reduce the proportion of in-hospital prescription changes not maintained by the PCP in adult patients with chronic diseases?
Does a discharge care bundle including medication reconciliation reduce the proportion of in-hospital prescription changes not maintained by the PCP in adult patients with chronic diseases?
A discharge care bundle including medication reconciliation significantly reduces treatment changes between hospital discharge and primary care, while also decreasing hospital readmissions and adverse drug reactions.
Answers are grounded in this paper and cite their sources.
Supports adoption of medication reconciliation care bundles at discharge; extends RCT evidence for continuity and fewer adverse outcomes in chronic disease.
OBJECTIVE: To compare the impact of a care bundle including medication reconciliation at discharge by a pharmacist versus standard of care, on continuity of therapeutic changes between hospital and primary care and outcome of patients, within 1 month after discharge. METHODS: Randomised controlled trial in 120 adult patients with at least one chronic disease and three current medications before admission, hospitalised in an infectious disease department of a tertiary hospital and discharged home. Patients were randomly assigned (1:1) to receive a discharge care bundle including medication reconciliation, counselling session and documentation transfer to primary care physician (PCP) (intervention group) or standard of care (control group). Primary outcome was the proportion of in-hospital prescription changes, not maintained by the PCP, 1 month after discharge. Secondary outcome measures included the proportion of patients experiencing early PCP's consultation, hospital readmissions or adverse reactions within 1-month postdischarge and cost of discharge prescriptions. RESULTS: Baseline characteristics were comparable between the two groups. One month after discharge, the proportion of in-hospital prescription changes, not maintained by the PCP, was 11% in the intervention group versus 24% in the control group (P = .007). The median delay before PCP's consultation was longer in the intervention group (30.5 vs 19.5 days, P = .013), there were fewer patients readmitted to hospital (3.4% vs 20.7%, P = .009, odds ratio (OR) = 0.13 [0.02-0.53]) and fewer patients who suffered from adverse drug reaction (7.0% vs 22.8%, P = .04, OR = 0.26 [0.07-0.78]). CONCLUSION: This care bundle resulted in the reduction of treatment changes between hospital discharge and primary care.
No takes yet. Share an insight, caveat, or question.
Bouchand et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: